Registered entities
ADARX PHARMACEUTICALS INC
Reg. No. 844145188United States
Innovation
27 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,480 times.
| Year | Filings |
|---|---|
| 2022 | 3 |
| 2023 | 11 |
| 2024 | 16 |
| 2025 | 23 |
| 2026 | 14 |
Social engagement
Social engagement: 15.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
19 investors on record; lead investors include SR One, Orbimed, Bain Capital Life Sciences, TCG Crossover.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 53% |
| Private equity | 3 | 16% |
| Other / undisclosed | 6 | 32% |
Hiring activity
Hires periodically
7 roles tracked across 4 of the last 12 months
12 Jun 2026 · Senior Research Associate, Discovery Biology
9 Jun 2026 · Sr. Intellectual Property Counsel (IP)
18 May 2026 · Research Associate I, Conjugation Chemistry
11 May 2026 · Director, Chemistry
8 May 2026 · Project Manager
Based on job postings tracked across public sources.
Recent activity
16 Jun 2026
Event
European Academy of Allergy and Clinical Immunology - EAACI
13 Jun 2026
Event
2026 Annual Meeting of the European Academy of Allergy and Clinical Immunology
12 Jun 2026
Event
EAACI2026